Baseline Visual Field Profile of Optic Neuritis: The Experience of the Optic Neuritis Treatment Trial

Optic Neuritis Study Group

Research output: Contribution to journalArticle

165 Citations (Scopus)

Abstract

The purpose of the present study was to determine the baseline visual field characteristics in 448 patients with acute optic neuritis who were entered into the Optic Neuritis Treatment Trial. The severity and pattern of visual field loss in both the affected and fellow eyes were classified. For affected eyes, diffuse visual field loss was present in 48.2% of eyes, central or centrocecal scotoma was present in 8.3% of eyes, altitudinal or other nervefiber bundle-type defects were present in 20.1% of eyes, and a variety of other defects were present in 23.4% of eyes. Visual field involvement was present in the fellow eye at baseline in 308 (68.8%) of the 448 patients. Evidence of a chiasmal or retrochiasmal visual field defect was present in 2.9% of the patients. Since a wide variety of visual field defects can occur with an acute attack of optic neuritis, the pattern of visual field loss is of limited utility in distinguishing optic neuritis from ischemic optic neuropathy and other optic nerve disorders. Asymptomatic visual field defects in the fellow eye are common.

Original languageEnglish (US)
Pages (from-to)231-234
Number of pages4
JournalArchives of Ophthalmology
Volume111
Issue number2
DOIs
StatePublished - 1993

Fingerprint

Optic Neuritis
Visual Fields
Scotoma
Therapeutics
Ischemic Optic Neuropathy
Optic Nerve

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Baseline Visual Field Profile of Optic Neuritis : The Experience of the Optic Neuritis Treatment Trial. / Optic Neuritis Study Group.

In: Archives of Ophthalmology, Vol. 111, No. 2, 1993, p. 231-234.

Research output: Contribution to journalArticle

@article{072531085cde47e5aac6035ed807f15f,
title = "Baseline Visual Field Profile of Optic Neuritis: The Experience of the Optic Neuritis Treatment Trial",
abstract = "The purpose of the present study was to determine the baseline visual field characteristics in 448 patients with acute optic neuritis who were entered into the Optic Neuritis Treatment Trial. The severity and pattern of visual field loss in both the affected and fellow eyes were classified. For affected eyes, diffuse visual field loss was present in 48.2{\%} of eyes, central or centrocecal scotoma was present in 8.3{\%} of eyes, altitudinal or other nervefiber bundle-type defects were present in 20.1{\%} of eyes, and a variety of other defects were present in 23.4{\%} of eyes. Visual field involvement was present in the fellow eye at baseline in 308 (68.8{\%}) of the 448 patients. Evidence of a chiasmal or retrochiasmal visual field defect was present in 2.9{\%} of the patients. Since a wide variety of visual field defects can occur with an acute attack of optic neuritis, the pattern of visual field loss is of limited utility in distinguishing optic neuritis from ischemic optic neuropathy and other optic nerve disorders. Asymptomatic visual field defects in the fellow eye are common.",
author = "{Optic Neuritis Study Group} and Keltner, {John L} and Johnson, {Chris A.} and Spurr, {John O.} and Beck, {Roy W.}",
year = "1993",
doi = "10.1001/archopht.1993.01090020085029",
language = "English (US)",
volume = "111",
pages = "231--234",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Baseline Visual Field Profile of Optic Neuritis

T2 - The Experience of the Optic Neuritis Treatment Trial

AU - Optic Neuritis Study Group

AU - Keltner, John L

AU - Johnson, Chris A.

AU - Spurr, John O.

AU - Beck, Roy W.

PY - 1993

Y1 - 1993

N2 - The purpose of the present study was to determine the baseline visual field characteristics in 448 patients with acute optic neuritis who were entered into the Optic Neuritis Treatment Trial. The severity and pattern of visual field loss in both the affected and fellow eyes were classified. For affected eyes, diffuse visual field loss was present in 48.2% of eyes, central or centrocecal scotoma was present in 8.3% of eyes, altitudinal or other nervefiber bundle-type defects were present in 20.1% of eyes, and a variety of other defects were present in 23.4% of eyes. Visual field involvement was present in the fellow eye at baseline in 308 (68.8%) of the 448 patients. Evidence of a chiasmal or retrochiasmal visual field defect was present in 2.9% of the patients. Since a wide variety of visual field defects can occur with an acute attack of optic neuritis, the pattern of visual field loss is of limited utility in distinguishing optic neuritis from ischemic optic neuropathy and other optic nerve disorders. Asymptomatic visual field defects in the fellow eye are common.

AB - The purpose of the present study was to determine the baseline visual field characteristics in 448 patients with acute optic neuritis who were entered into the Optic Neuritis Treatment Trial. The severity and pattern of visual field loss in both the affected and fellow eyes were classified. For affected eyes, diffuse visual field loss was present in 48.2% of eyes, central or centrocecal scotoma was present in 8.3% of eyes, altitudinal or other nervefiber bundle-type defects were present in 20.1% of eyes, and a variety of other defects were present in 23.4% of eyes. Visual field involvement was present in the fellow eye at baseline in 308 (68.8%) of the 448 patients. Evidence of a chiasmal or retrochiasmal visual field defect was present in 2.9% of the patients. Since a wide variety of visual field defects can occur with an acute attack of optic neuritis, the pattern of visual field loss is of limited utility in distinguishing optic neuritis from ischemic optic neuropathy and other optic nerve disorders. Asymptomatic visual field defects in the fellow eye are common.

UR - http://www.scopus.com/inward/record.url?scp=0027404033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027404033&partnerID=8YFLogxK

U2 - 10.1001/archopht.1993.01090020085029

DO - 10.1001/archopht.1993.01090020085029

M3 - Article

C2 - 8431161

AN - SCOPUS:0027404033

VL - 111

SP - 231

EP - 234

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 2

ER -